Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veru Inc. - Common Stock (NQ:VERU)

0.5330 +0.0130 (+2.50%)
Streaming Delayed Price Updated: 10:59 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Veru Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Which stocks are experiencing notable movement on Monday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
These stocks are moving in today's session
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Dow Edges Higher; AT&T Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Critical Insights From Veru Analyst Ratings: What You Need To Know
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
A Peek at Veru's Future Earnings
Via Benzinga
Which stocks are experiencing notable movement on Tuesday?
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Earnings Scheduled For February 13, 2025
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough
Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025. 
Via Benzinga
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December
Via Benzinga
Topics Economy
Exposures Interest Rates
These stocks that are showing activity before the opening bell on Monday.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
Veru jumps after selling FC2 Female Condom business for $18 million, reducing workforce by 90%. 
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024
VERU stock results show that Veru beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Comstock And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
VERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024
VERU stock results show that Veru missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
Via Benzinga
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
The 3 Best Penny Stocks to Buy in February 2024
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies. 
Via InvestorPlace
8 Consumer Staples Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 112 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.